Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
333.8 USD | +1.70% |
|
+2.11% | +52.89% |
11/07 | TD Cowen Adjusts Price Target on United Therapeutics to $350 From $270, Maintains Buy Rating | MT |
11/07 | Everything's going according to plan | ![]() |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.89% | 1.46TCr | |
+24.07% | 4.8TCr | |
+1.89% | 4.24TCr | |
+44.08% | 4.15TCr | |
+27.18% | 3.16TCr | |
+21.45% | 2.86TCr | |
-6.35% | 2.8TCr | |
+45.26% | 1.41TCr | |
+3.45% | 1.26TCr | |
-2.92% | 1.17TCr |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Corsair Pharma, Inc. announced that it has received funding from United Therapeutics Corporation